Analysis

Procter & Gamble to report Q2 earnings next week. Here’s what to expect

Procter & Gamble Company (NYSE: PG) is gearing up for its latest earnings report while navigating a challenging market environment marked by

McCormick (MKC) expected to report higher revenue and earnings in Q4 2025

Shares of McCormick & Company, Incorporated (NYSE: MKC) stayed green on Wednesday. The stock has gained 4% in the past three months.

Earnings Preview: What to watch as Intel (INTC) prepares to report Q4 results

For Intel Corporation (NASDAQ: INTC), 2025 marked a recovery year, as the company made notable progress towards achieving its technological and operational

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Morgan Stanley (MS) Q4 2025 Earnings: Revenue and profits beat estimates

Morgan Stanley (NYSE: MS) reported its fourth quarter 2025 earnings results today. Net revenues increased 10% year-over-year to $17.9 billion. Net income applicable to common shareholders was $4.3 billion, or

January 15, 2026

Key highlights from BlackRock’s (BLK) Q4 2025 earnings results

BlackRock, Inc. (NYSE: BLK) reported its fourth quarter 2025 earnings results today. Revenue increased 23% year-over-year to $7 billion. Net income decreased 33% to $1.13 billion, or $7.16 per share,

January 15, 2026

Procter & Gamble to report Q2 earnings next week. Here’s what to expect

Procter & Gamble Company (NYSE: PG) is gearing up for its latest earnings report while navigating a challenging market environment marked by intensifying competition and evolving consumer behavior. Over the

January 14, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top